Industry: Service & Software
Published Date: 2025-09-06
Pages: 96 Pages
Report ld: 4950385
Request Sample
Customized Report
Artificial Intelligence Eye Screening Software Market Size(US$)

CAGR 2025-2031
84.0%
Market Size,2031
USD 15,470
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Artificial Intelligence Eye Screening Software market size was US$ 227 million in 2024 and is forecast to a readjusted size of US$ 15470 million by 2031 with a CAGR of 84.0% during the forecast period 2025-2031.
Artificial intelligence (AI) is becoming established as a new method for analysing ophthalmological data, and unveiling new clinical and pathogenic insights into retinal diseases. AI-based algorithms are largely employed in the field of the most prevalent retinal diseases, including diabetic retinopathy, age-related macular degeneration and myopia.
Diabetes continues to rise throughout the United States and worldwide. Estimates show that the prevalence of diabetes mellitus will rise to 578 million people (10.2%) by the year 2030 and 700 million people (10.9%) by the year 2045. This increase in the prevalence of diabetes can also lead to a corresponding increase in diabetic complications, including nephropathy, cardiovascular disease, neuropathy, and retinopathy. It is estimated that vision-threatening diabetic retinopathy (vtDR) is present in around 22% of patients with diabetes, with clinically significant macular edema present in about 4% of patients, although the numbers can widely vary based on the population and access to care. Regardless of the exact numbers, there is no doubt that diabetic retinopathy remains a significant health burden and cause of visual loss. Early detection of diabetic retinopathy is key, because early treatment and lifestyle modifications can help prevent or minimize vision-threatening complications.
The global Artificial Intelligence Eye Screening Software market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Artificial Intelligence Eye Screening Software market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Age-Related Macular Degeneration (AMD) in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Great Health Scene in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Artificial Intelligence Eye Screening Software value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Diabetic Retinopathy (DR)
1.2.3 Age-Related Macular Degeneration (AMD)
1.2.4 Myopia
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Institutions
1.3.3 Great Health Scene
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence Eye Screening Software Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Artificial Intelligence Eye Screening Software Revenue Market Share by Region (2020-2025)
2.4 Global Artificial Intelligence Eye Screening Software Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Artificial Intelligence Eye Screening Software Market Size and Prospective (2020-2031)
2.5.2 Europe Artificial Intelligence Eye Screening Software Market Size and Prospective (2020-2031)
2.5.3 Asia-Pacific Artificial Intelligence Eye Screening Software Market Size and Prospective (2020-2031)
2.5.4 Latin America Artificial Intelligence Eye Screening Software Market Size and Prospective (2020-2031)
2.5.5 Middle East & Africa Artificial Intelligence Eye Screening Software Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Artificial Intelligence Eye Screening Software Historic Market Size by Type (2020-2025)
3.2 Global Artificial Intelligence Eye Screening Software Forecasted Market Size by Type (2026-2031)
3.3 Different Types Artificial Intelligence Eye Screening Software Representative Players
4 Breakdown Data by Application
4.1 Global Artificial Intelligence Eye Screening Software Historic Market Size by Application (2020-2025)
4.2 Global Artificial Intelligence Eye Screening Software Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Artificial Intelligence Eye Screening Software Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Artificial Intelligence Eye Screening Software Players by Revenue (2020-2025)
5.1.2 Global Artificial Intelligence Eye Screening Software Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Artificial Intelligence Eye Screening Software Revenue
5.4 Global Artificial Intelligence Eye Screening Software Market Concentration Analysis
5.4.1 Global Artificial Intelligence Eye Screening Software Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Eye Screening Software Revenue in 2024
5.5 Global Key Players of Artificial Intelligence Eye Screening Software Head office and Area Served
5.6 Global Key Players of Artificial Intelligence Eye Screening Software, Product and Application
5.7 Global Key Players of Artificial Intelligence Eye Screening Software, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Artificial Intelligence Eye Screening Software Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Artificial Intelligence Eye Screening Software Market Size by Type (2020-2025)
6.1.2.2 North America Artificial Intelligence Eye Screening Software Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Artificial Intelligence Eye Screening Software Market Size by Application (2020-2025)
6.1.3.2 North America Artificial Intelligence Eye Screening Software Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Artificial Intelligence Eye Screening Software Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Artificial Intelligence Eye Screening Software Market Size by Type (2020-2025)
6.2.2.2 Europe Artificial Intelligence Eye Screening Software Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Artificial Intelligence Eye Screening Software Market Size by Application (2020-2025)
6.2.3.2 Europe Artificial Intelligence Eye Screening Software Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments and Downstream
6.3.1 Asia-Pacific Artificial Intelligence Eye Screening Software Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Artificial Intelligence Eye Screening Software Market Size by Type (2020-2025)
6.3.2.2 Asia-Pacific Artificial Intelligence Eye Screening Software Market Share by Type (2020-2025)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Artificial Intelligence Eye Screening Software Market Size by Application (2020-2025)
6.3.3.2 Asia-Pacific Artificial Intelligence Eye Screening Software Market Share by Application (2020-2025)
6.3.4 Asia-Pacific Market Trend and Opportunities
6.4 Latin America Market: Players, Segments and Downstream
6.4.1 Latin America Artificial Intelligence Eye Screening Software Revenue by Company (2020-2025)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Artificial Intelligence Eye Screening Software Market Size by Type (2020-2025)
6.4.2.2 Latin America Artificial Intelligence Eye Screening Software Market Share by Type (2020-2025)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Artificial Intelligence Eye Screening Software Market Size by Application (2020-2025)
6.4.3.2 Latin America Artificial Intelligence Eye Screening Software Market Share by Application (2020-2025)
6.4.4 Latin America Market Trend and Opportunities
6.5 Middle East & Africa Market: Players, Segments and Downstream
6.5.1 Middle East & Africa Artificial Intelligence Eye Screening Software Revenue by Company (2020-2025)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Artificial Intelligence Eye Screening Software Market Size by Type (2020-2025)
6.5.2.2 Middle East & Africa Artificial Intelligence Eye Screening Software Market Share by Type (2020-2025)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Artificial Intelligence Eye Screening Software Market Size by Application (2020-2025)
6.5.3.2 Middle East & Africa Artificial Intelligence Eye Screening Software Market Share by Application (2020-2025)
6.5.4 Middle East & Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 Airdoc Technology
7.1.1 Airdoc Technology Company Details
7.1.2 Airdoc Technology Business Overview
7.1.3 Airdoc Technology Artificial Intelligence Eye Screening Software Introduction
7.1.4 Airdoc Technology Revenue in Artificial Intelligence Eye Screening Software Business (2020-2025)
7.1.5 Airdoc Technology Recent Development
7.2 Digital Diagnostics
7.2.1 Digital Diagnostics Company Details
7.2.2 Digital Diagnostics Business Overview
7.2.3 Digital Diagnostics Artificial Intelligence Eye Screening Software Introduction
7.2.4 Digital Diagnostics Revenue in Artificial Intelligence Eye Screening Software Business (2020-2025)
7.2.5 Digital Diagnostics Recent Development
7.3 Eyenuk
7.3.1 Eyenuk Company Details
7.3.2 Eyenuk Business Overview
7.3.3 Eyenuk Artificial Intelligence Eye Screening Software Introduction
7.3.4 Eyenuk Revenue in Artificial Intelligence Eye Screening Software Business (2020-2025)
7.3.5 Eyenuk Recent Development
7.4 RetinaLyze System
7.4.1 RetinaLyze System Company Details
7.4.2 RetinaLyze System Business Overview
7.4.3 RetinaLyze System Artificial Intelligence Eye Screening Software Introduction
7.4.4 RetinaLyze System Revenue in Artificial Intelligence Eye Screening Software Business (2020-2025)
7.4.5 RetinaLyze System Recent Development
7.5 Optomed
7.5.1 Optomed Company Details
7.5.2 Optomed Business Overview
7.5.3 Optomed Artificial Intelligence Eye Screening Software Introduction
7.5.4 Optomed Revenue in Artificial Intelligence Eye Screening Software Business (2020-2025)
7.5.5 Optomed Recent Development
7.6 Sibionics Technology
7.6.1 Sibionics Technology Company Details
7.6.2 Sibionics Technology Business Overview
7.6.3 Sibionics Technology Artificial Intelligence Eye Screening Software Introduction
7.6.4 Sibionics Technology Revenue in Artificial Intelligence Eye Screening Software Business (2020-2025)
7.6.5 Sibionics Technology Recent Development
7.7 Aeye Health
7.7.1 Aeye Health Company Details
7.7.2 Aeye Health Business Overview
7.7.3 Aeye Health Artificial Intelligence Eye Screening Software Introduction
7.7.4 Aeye Health Revenue in Artificial Intelligence Eye Screening Software Business (2020-2025)
7.7.5 Aeye Health Recent Development
7.8 VUNO
7.8.1 VUNO Company Details
7.8.2 VUNO Business Overview
7.8.3 VUNO Artificial Intelligence Eye Screening Software Introduction
7.8.4 VUNO Revenue in Artificial Intelligence Eye Screening Software Business (2020-2025)
7.8.5 VUNO Recent Development
7.9 Medimaging Integrated Solution
7.9.1 Medimaging Integrated Solution Company Details
7.9.2 Medimaging Integrated Solution Business Overview
7.9.3 Medimaging Integrated Solution Artificial Intelligence Eye Screening Software Introduction
7.9.4 Medimaging Integrated Solution Revenue in Artificial Intelligence Eye Screening Software Business (2020-2025)
7.9.5 Medimaging Integrated Solution Recent Development
7.10 EyRIS (SELENA+)
7.10.1 EyRIS (SELENA+) Company Details
7.10.2 EyRIS (SELENA+) Business Overview
7.10.3 EyRIS (SELENA+) Artificial Intelligence Eye Screening Software Introduction
7.10.4 EyRIS (SELENA+) Revenue in Artificial Intelligence Eye Screening Software Business (2020-2025)
7.10.5 EyRIS (SELENA+) Recent Development
7.11 Vistel
7.11.1 Vistel Company Details
7.11.2 Vistel Business Overview
7.11.3 Vistel Artificial Intelligence Eye Screening Software Introduction
7.11.4 Vistel Revenue in Artificial Intelligence Eye Screening Software Business (2020-2025)
7.11.5 Vistel Recent Development
7.12 RETINA-AI Health
7.12.1 RETINA-AI Health Company Details
7.12.2 RETINA-AI Health Business Overview
7.12.3 RETINA-AI Health Artificial Intelligence Eye Screening Software Introduction
7.12.4 RETINA-AI Health Revenue in Artificial Intelligence Eye Screening Software Business (2020-2025)
7.12.5 RETINA-AI Health Recent Development
7.13 Acer Medical
7.13.1 Acer Medical Company Details
7.13.2 Acer Medical Business Overview
7.13.3 Acer Medical Artificial Intelligence Eye Screening Software Introduction
7.13.4 Acer Medical Revenue in Artificial Intelligence Eye Screening Software Business (2020-2025)
7.13.5 Acer Medical Recent Development
8 Artificial Intelligence Eye Screening Software Market Dynamics
8.1 Artificial Intelligence Eye Screening Software Industry Trends
8.2 Artificial Intelligence Eye Screening Software Market Drivers
8.3 Artificial Intelligence Eye Screening Software Market Challenges
8.4 Artificial Intelligence Eye Screening Software Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Artificial Intelligence Eye Screening Software market is projected to grow from US$ 399 million in 2025 to US$ 27160 million by 2032, at a CAGR of 84.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-31
Pages: 143
USD 4900.00
(Single User License)
The global Artificial Intelligence Eye Screening Software market size was US$ 399 million in 2025 and is forecast to reach a readjusted size of US$ 27160 million by 2032 with a CAGR of 84.0% during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 94
USD 4250.00
(Single User License)
The global market for Artificial Intelligence Eye Screening Software was estimated to be worth US$ 399 million in 2025 and is projected to reach US$ 27160 million, growing at a CAGR of 84.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 115
USD 3950.00
(Single User License)
The global Artificial Intelligence Eye Screening Software market was valued at US$ 399 million in 2025 and is anticipated to reach US$ 27160 million by 2032, at a CAGR of 84.0% from 2026 to 2032.
Published Date: 2026-01-16
Pages: 117
USD 2900.00
(Single User License)
The global Artificial Intelligence Eye Screening Software market is projected to grow from US$ 227 million in 2024 to US$ 15470 million by 2031, at a CAGR of 84.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 143
USD 4900.00
(Single User License)
The global market for Artificial Intelligence Eye Screening Software was estimated to be worth US$ 227 million in 2024 and is forecast to a readjusted size of US$ 15470 million by 2031 with a CAGR of 84.0% during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 110
USD 3950.00
(Single User License)
The global market for Artificial Intelligence Eye Screening Software was valued at US$ 227 million in the year 2024 and is projected to reach a revised size of US$ 15470 million by 2031, growing at a CAGR of 84.0% during the forecast period.
Published Date: 2025-03-11
Pages: 81
USD 2900.00
(Single User License)
Artificial intelligence (AI) is becoming established as a new method for analysing ophthalmological data, and unveiling new clinical and pathogenic insights into retinal diseases. AI-based algorithms are largely employed in the field of the most prevalent retinal diseases, including diabetic retinopathy, age-related macular degeneration and myopia.
Published Date: 2024-04-22
Pages: 89
USD 2900.00
(Single User License)
Artificial intelligence (AI) is becoming established as a new method for analysing ophthalmological data, and unveiling new clinical and pathogenic insights into retinal diseases. AI-based algorithms are largely employed in the field of the most prevalent retinal diseases, including diabetic retinopathy, age-related macular degeneration and myopia.
Published Date: 2024-04-22
Pages: 113
USD 4350.00
(Single User License)
Artificial intelligence (AI) is becoming established as a new method for analysing ophthalmological data, and unveiling new clinical and pathogenic insights into retinal diseases. AI-based algorithms are largely employed in the field of the most prevalent retinal diseases, including diabetic retinopathy, age-related macular degeneration and myopia.
Published Date: 2024-04-22
Pages: 135
USD 4900.00
(Single User License)
The global Artificial Intelligence Eye Screening Software market is projected to grow from US$ 399 million in 2025 to US$ 27160 million by 2032, at a CAGR of 84.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 143
The global Artificial Intelligence Eye Screening Software market size was US$ 399 million in 2025 and is forecast to reach a readjusted size of US$ 27160 million by 2032 with a CAGR of 84.0% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 94
The global market for Artificial Intelligence Eye Screening Software was estimated to be worth US$ 399 million in 2025 and is projected to reach US$ 27160 million, growing at a CAGR of 84.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 115
The global Artificial Intelligence Eye Screening Software market was valued at US$ 399 million in 2025 and is anticipated to reach US$ 27160 million by 2032, at a CAGR of 84.0% from 2026 to 2032.
Published: 2026-01-16
Pages: 117
The global Artificial Intelligence Eye Screening Software market is projected to grow from US$ 227 million in 2024 to US$ 15470 million by 2031, at a CAGR of 84.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 143
The global market for Artificial Intelligence Eye Screening Software was estimated to be worth US$ 227 million in 2024 and is forecast to a readjusted size of US$ 15470 million by 2031 with a CAGR of 84.0% during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 110
The global market for Artificial Intelligence Eye Screening Software was valued at US$ 227 million in the year 2024 and is projected to reach a revised size of US$ 15470 million by 2031, growing at a CAGR of 84.0% during the forecast period.
Published: 2025-03-11
Pages: 81
Artificial intelligence (AI) is becoming established as a new method for analysing ophthalmological data, and unveiling new clinical and pathogenic insights into retinal diseases. AI-based algorithms are largely employed in the field of the most prevalent retinal diseases, including diabetic retinopathy, age-related macular degeneration and myopia.
Published: 2024-04-22
Pages: 89
Artificial intelligence (AI) is becoming established as a new method for analysing ophthalmological data, and unveiling new clinical and pathogenic insights into retinal diseases. AI-based algorithms are largely employed in the field of the most prevalent retinal diseases, including diabetic retinopathy, age-related macular degeneration and myopia.
Published: 2024-04-22
Pages: 113
Artificial intelligence (AI) is becoming established as a new method for analysing ophthalmological data, and unveiling new clinical and pathogenic insights into retinal diseases. AI-based algorithms are largely employed in the field of the most prevalent retinal diseases, including diabetic retinopathy, age-related macular degeneration and myopia.
Published: 2024-04-22
Pages: 135
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now